Prosecution Insights
Last updated: October 04, 2026

Guangdong Aglaia Optoelectronic Materials Co. Ltd.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

6 pending office actions • 3 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days

Analysis

Guangdong Aglaia Optoelectronic Materials Co. Ltd. has 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 6 actions are distributed among 6 distinct examiners, meaning every pending matter is being reviewed by a different individual. These actions are further organized into 3 distinct art units, suggesting that the examiners are grouped into separate supervisory environments within the USPTO.

The busiest examiner, OTTON, ALICIA L, is responsible for 1 pending office action. Because the busiest examiner handles only 1 of the total pending actions, the portfolio shows no examiner concentration. This requires the company to manage 6 distinct examiner relationships. However, the 3 distinct art units indicate that the pending matters are likely related to specific technical sub-fields, which may allow for some consistency in prosecution strategy within each unit. The current workload represents a set of reviews across the biotechnology and pharmaceutical sectors handled by the assigned staff.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
6
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (33%)
2
Medium (33%)
2
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (17%)
§102 only1 (17%)
§112 only2 (33%)
Multi-statute (no §101)2 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
3
Business / Other
50% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
OTTON, ALICIA L 1 64.9% +9.4%
HAVLIN, ROBERT H 1 51.5% +28.1%
GARRETT, DAWN L 1 72.6% +10.3%
YANG, JAY LEE 1 73.9% +2.0%
DEGUIRE, SEAN M 1 60.7% +28.7%
MCDOWELL, BRIAN E 1 74.1% +30.8%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18562205 ORGANIC ELECTROLUMINESCENT MATERIALS CONTAINING B-N FUSED RINGS, AND APPLICATIONS THEREOF HAVLIN, ROBERT H —
18562177 HETEROCYCLIC MODIFIED PLATINUM COMPLEX CONTAINING ONCN TETRADENTATE LIGAND GARRETT, DAWN L —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17777027 IMIDAZOPYRIDINE-BASED ARYLAMINE COMPOUND AND USE THEREOF MCDOWELL, BRIAN E 28d overdue
18562205 ORGANIC ELECTROLUMINESCENT MATERIALS CONTAINING B-N FUSED RINGS, AND APPLICATIONS THEREOF HAVLIN, ROBERT H —
18562177 HETEROCYCLIC MODIFIED PLATINUM COMPLEX CONTAINING ONCN TETRADENTATE LIGAND GARRETT, DAWN L —
17926969 ONCN QUADRIDENTATE LIGAND-CONTAINING PLATINUM COMPLEX AND APPLICATION THEREOF IN ORGANIC LIGHT-EMITTING DIODE DEGUIRE, SEAN M —

Top Art Units

Art UnitApps
1626 1
1786 1
1624 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18873893 ORGANIC ELECTROLUMINESCENT MATERIAL AND USE THEREOF OTTON, ALICIA L — §102 Non-Final OA — Pending Dec 11, 2024
18562205 ORGANIC ELECTROLUMINESCENT MATERIALS CONTAINING B-N FUSED RINGS, AND APPLICATIONS THEREOF HAVLIN, ROBERT H 1626 §102§112 Non-Final OA — Pending Nov 17, 2023
18562177 HETEROCYCLIC MODIFIED PLATINUM COMPLEX CONTAINING ONCN TETRADENTATE LIGAND GARRETT, DAWN L — §103§112 Non-Final OA — Pending Nov 17, 2023
18038679 DIVALENT PLATINUM COMPLEX YANG, JAY LEE — §112 Non-Final OA — Pending May 24, 2023
17926969 ONCN QUADRIDENTATE LIGAND-CONTAINING PLATINUM COMPLEX AND APPLICATION THEREOF IN ORGANIC LIGHT-EMITTING DIODE DEGUIRE, SEAN M 1786 §103 Non-Final OA — Pending Nov 21, 2022
17777027 IMIDAZOPYRIDINE-BASED ARYLAMINE COMPOUND AND USE THEREOF MCDOWELL, BRIAN E 1624 §112 Non-Final OA 28d overdue Pending May 14, 2022

Managing Guangdong Aglaia Optoelectronic Materials Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month